Shannon M. Mumenthaler Lawrence J. Ellison Institute for Transformative Medicine University of Southern California (USC) Biography Publications Institution JoVE Articles Shannon M. Mumenthaler has not added a biography. If you are Shannon M. Mumenthaler and would like to personalize this page please email our Author Liaison for assistance. Publications Progress Towards Computational 3-D Multicellular Systems Biology Advances in Experimental Medicine and Biology. 2016 | Pubmed ID: 27739051 Single Cell Dynamic Phenotyping Scientific Reports. Oct, 2016 | Pubmed ID: 27708391 Quantifying Differences in Cell Line Population Dynamics Using CellPD BMC Systems Biology. Sep, 2016 | Pubmed ID: 27655224 Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors PLoS Computational Biology. Aug, 2016 | Pubmed ID: 27560187 Dual Transcript and Protein Quantification in a Massive Single Cell Array Lab on a Chip. Oct, 2016 | Pubmed ID: 27546183 A High-content Image-based Method for Quantitatively Studying Context-dependent Cell Population Dynamics Scientific Reports. Jul, 2016 | Pubmed ID: 27452732 Significance of Duon Mutations in Cancer Genomes Scientific Reports. Jun, 2016 | Pubmed ID: 27272679 Phosphorylated Ribosomal S6 (p-rpS6) As a Post-treatment Indicator of HER2 Signalling Targeted Drug Resistance Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 2015 | Pubmed ID: 26329528 The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells Cancer Informatics. 2015 | Pubmed ID: 26244007 Predictive Modeling of Drug Response in Non-Hodgkin's Lymphoma PloS One. 2015 | Pubmed ID: 26061425 Anti-MET ImmunoPET for Non-small Cell Lung Cancer Using Novel Fully Human Antibody Fragments Molecular Cancer Therapeutics. Nov, 2014 | Pubmed ID: 25143449 The Need for Integrative Computational Oncology: An Illustrated Example Through MMP-Mediated Tissue Degradation Frontiers in Oncology. 2013 | Pubmed ID: 23898463 A Physical Sciences Network Characterization of Non-tumorigenic and Metastatic Cells Scientific Reports. 2013 | Pubmed ID: 23618955 Cancer As a Moving Target: Understanding the Composition and Rebound Growth Kinetics of Recurrent Tumors Evolutionary Applications. Jan, 2013 | Pubmed ID: 23396647 Evolutionary Modeling of Combination Treatment Strategies to Overcome Resistance to Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Molecular Pharmaceutics. Dec, 2011 | Pubmed ID: 21995722 Pharmacologic Inhibition of Pim Kinases Alters Prostate Cancer Cell Growth and Resensitizes Chemoresistant Cells to Taxanes Molecular Cancer Therapeutics. Oct, 2009 | Pubmed ID: 19825806 CD4+ NK Cells Can Be Productively Infected with HIV, Leading to Downregulation of CD4 Expression and Changes in Function Virology. Apr, 2009 | Pubmed ID: 19251297 Disruption of Arginase II Alters Prostate Tumor Formation in TRAMP Mice The Prostate. Oct, 2008 | Pubmed ID: 18663728 Expression of Arginase II in Prostate Cancer International Journal of Oncology. Feb, 2008 | Pubmed ID: 18202758 Discriminação e Caracterização de Populações Heterocelulares Usando Técnicas de Imagem Quantitativa Colleen M. Garvey1, Torin A. Gerhart1, Shannon M. Mumenthaler1 1Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California (USC) JoVE 55844 Biology
Discriminação e Caracterização de Populações Heterocelulares Usando Técnicas de Imagem Quantitativa Colleen M. Garvey1, Torin A. Gerhart1, Shannon M. Mumenthaler1 1Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California (USC) JoVE 55844 Biology
